These guidelines are for the interest of the general public and in particular, manufacturers of herbal remedies/dietary supplements made in Nigeria. The document emphasizes that no herbal remedies/dietary supplements shall be manufactured, imported, exported, advertised, sold, distributed or used in Nigeria unless it has been registered under the provisions of the National Agency for Food and Drug Administration and Control (NAFDAC) Act CAP N1 (LFN) 2004, other related Legislations and the accompanying guidelines.

These regulations apply to procedures and processes that will ensure appropriate importation, exportation, manufacturing, storage, warehousing, distribution, inspection, use for medical and scientific purposes, disposal as well as documentation of controlled medicines in Nigeria, in such a manner as to maintain the security and integrity of the product throughout the supply chain. They provide information on prohibition, application of registration, validity, Suspension or cancellation of certificate of registration, permit or authorization, importation of controlled medicines, labelling, storage facility, distribution, procurement, selection and quantification, inspection, dispensing disposal of controlled medicines, penalty, and forfeiture after conviction.

This guideline is technically and structurally inspired by Health Canada’s guidance document on harmonized requirements for the licensing of vaccines and guidelines for the preparation of an application and the World Health Organization (WHO) working document on vaccine prequalification dossier. This guideline document has been developed in pursuance of the National Agency for Food and Drug Administration and Control (NAFDAC) Act Cap. N1, LFN 2014 and made to provide guidance to applicants on the organization of information to be provided to the agency in seeking marketing authorization for Vaccines for human use. The document applies to all vaccines to be authorized for human use, regardless of where they are manufactured.

These regulations apply to all advertisements and promotion of cosmetics products (both single and compound entity) manufactured, imported, exported, sold, distributed or used in Nigeria.

The intention of this document is to provide acceptable principles for the registration of biosimilar products that are claimed to be similar to RBP of assured quality, safety, and efficacy that have been licensed based on a full registration dossier by a stringent regulatory authority. On the basis of proven similarity, the registration of a biosimilar will rely, in part, on non-clinical and clinical data generated with an already licensed RBP.

These regulations provide for the registration of all cosmetics manufactured, imported, exported, advertised, sold, distributed or used in Nigeria. It provides information on labelling information and the net content of cosmetic products.

This document is for the interest of the general public and in particular, a non-governmental organization that wish to import NAFDAC regulated items. It emphasizes that no food, drug, cosmetics, packaged water, detergent, the medical device shall be manufactured, imported, exported, advertised, sold, distributed or used in Nigeria unless it has been registered in accordance with the provisions of NAFDAC Act CAP N1 (LFN) 2004, other related legislations and the accompanying guidelines.

These regulations guide the manufacture, import, export and distribution of safe cosmetics products and penalties for offenders of the regulations.

These regulations apply to all advertisements or promotion of drug products both single and compound entities, manufactured, imported, exported, sold, distributed or used in Nigeria. It emphasizes that no person shall advertise any drug or related product unless it has been registered by the Agency. No person shall advertise any drug product unless the advertisement has the pre-clearance and approval of the Agency; and no person shall engage in consumer promotions of any kind, including but not limited to gifts or free samples of drug or related products to the consuming public.

This document proposes a strategic approach to increase accessibility to testing as new testing modalities are available and to complement Nigeria Center for Desktop Control’s work with donors, partners and the private sector to rapidly scale testing capacity to every state.

Pregnant women have a higher risk of severe illness when infected with viruses from the same family as COVID-19 and other viral respiratory infections, such as influenza. Therefore, this document provides guidelines for pregnant women and nursing mothers during the COVID-19 pandemic.

This memorandum explains the sections and terms in the 2014 National Health Act. The Act stipulates the regulation, development and management of a health system and sets standards for rendering health services in Nigeria.

The overall goal of this national strategic framework is to reduce HIV/AIDS incidence and prevalence, provide equitable prevention, care, treatment, and support, and mitigate its impact among women, children, and other vulnerable groups and the general population in Nigeria by 25% by the Year 2009.

The goal of this policy is to promote and sustain equity, efficiency, accessibility, and quality in health care provisioning through collaborative relationships between the public and private sectors.

This Act repeals the National Health Insurance Scheme Act Cap. N42, Laws of the Federation of Nigeria 2004 and enacts the National Health Insurance Authority Act to ensure an effective implementation of a national health insurance policy that ensures the attainment of Universal health Coverage in Nigeria.

This is an Act to provide a framework for the regulation, development, and management of a national health system and set standards for rendering health services in the federation.

The overall goal of this HIV/AIDS policy is to control the spread of HIV in Nigeria, to provide equitable care and support for those infected by HIV, and to mitigate its impact to the point where it is no longer of public health, social and economic concern, such that all Nigerians will be able to achieve socially and economically productive lives free of the disease and its effects.

The goal of this revised National Policy on HIV/AIDS is to control the spread of HIV/AIDS in Nigeria and mitigate its social and economic impact.

The overall goal of the National Child Health Policy is to ensure the survival and healthy growth and development of the Nigerian child. It covers newborns, under-five, and school-age children while adolescents are covered by other policies.

This strategic plan outlines in detail the strategy to control cancer in Kebbi state for the period between 2019-2023.